Sees Q4 adjusted EBITDA $3M-$4M.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFMD:
- LifeMD options imply 13.7% move in share price post-earnings
- LifeMD announces new, lower cash-pay price for GLP-1 medications
- Novo launches introductory self-pay offer for Wegovy, Ozempic for $199 per month
- Options Volatility and Implied Earnings Moves Today, November 17, 2025
- Lifemd, Inc. (LFMD) Q3 Earnings Cheat Sheet